Search
01/08/2024
The impact of diagnosis delay on European patients with generalised myasthenia gravis
Cortes-Vicente, E, Borsi, AJ, Gary, C, Noel, WGJ, Lee, JMS, Karmous, W, Zhang, QY, Gandhi, KH, Batista, AE, Decourcy, JJ, Barlow, SG, Birija, SL, Gibson, GA. The impact of diagnosis delay on European patients with generalised myasthenia gravis. Annals of Clinical and Translational Neurology. 2024; 11(9)DOI:10.1002/acn3.52122. PMID:39090840. IF:3.900(Q1/3D).
01/08/2024
ANTI-HNK-1 IGM AND SNFL LEVELS ARE POTENTIAL BIOMARKERS FOR MONITORING DISEASE ACTIVITY IN ANTI-MAG NEUROPATHY
Pascual-Goñi, E, Martín-Aguilar, L, Lleixà, C, Mariscal, A, Tejada-Illa, C, Caballero-Avila, M, Martinez-Hernandez, E, Serfim, A, Moga, E, Rojas-García, R, López-Pardo, J, Novelli, S, Gallardo, E, Sabater, L, Querol, L. ANTI-HNK-1 IGM AND SNFL LEVELS ARE POTENTIAL BIOMARKERS FOR MONITORING DISEASE ACTIVITY IN ANTI-MAG NEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
ANTI-CASPR1 AUTOIMMUNE NODOPATHY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION
Collet-Vidiella, R, Mederer-Fernandez, T, Caballero-Avila, M, Tejada-Illa, C, Pascual-Goñi, E, Martín-Aguilar, L, Lleixà, C, Querol, L. ANTI-CASPR1 AUTOIMMUNE NODOPATHY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
ANTI-CASPR1 ANTIBODIES ARE ASSOCIATED WITH HLA-DRB1*03:01 ALLELES
Lleixà, C, Martínez-Martínez, L, Pascual-Goñi, E, Martín-Aguilar, L, Caballero-Avila, M, Collet, R, Illa, CT, Gallardo, E, Boera-Carnicero, G, Calahorro, V, Martín, OD, Callegari, I, Cortese, A, Delmont, E, Devaux, J, Giannotta, C, Nobie-Orazio, E, Höftberger, R, Herdewyn, S, Carvajal, A, Torné, L, Jericó-Pascual, I, Querol, L. ANTI-CASPR1 ANTIBODIES ARE ASSOCIATED WITH HLA-DRB1*03:01 ALLELES. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
CHARACTERISTICS OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY SUBTYPES: RESULTS FROM A MULTINATIONAL, REAL-WORLD SURVEY
Querol, L, Borsi, A, Gary, C, Noel, W, Karmous, W, DeCourcy, J, Wright, J, Taylor, Y, Iqbal, H, Rinaldi, S. CHARACTERISTICS OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY SUBTYPES: RESULTS FROM A MULTINATIONAL, REAL-WORLD SURVEY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
LONGITUDINAL GAIT ASSESSMENT USING A WEARABLE SYSTEM DETECTS CLINICALLY SIGNIFICANT CHANGES IN PATIENTS WITH PERIPHERAL NEUROPATHIES
Illa, CT, Pegueroles, J, Claramunt-Molet, M, Pi-Cervera, A, Heras-Delgado, A, Gascón-Fontal, J, Idelsohn-Zielonka, S, Vidal, N, Martín-Aguilar, L, Caballero-Avila, M, Lleixà, C, Llansó, L, Rojas-García, R, Querol, L, Pascual-Goñi, E. LONGITUDINAL GAIT ASSESSMENT USING A WEARABLE SYSTEM DETECTS CLINICALLY SIGNIFICANT CHANGES IN PATIENTS WITH PERIPHERAL NEUROPATHIES. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
EMPASIPRUBART (ARGX-117) IN MULTIFOCAL MOTOR NEUROPATHY: INITIAL SAFETY AND EFFICACY DATA OF THE PHASE 2 ARDA STUDY
van der Pol, WL, Peric, S, Querol, L, Hussain, Y, Cadour, S, Van de Walle, I, Persson, E, Van Hoomissen, I, Mashchenko, O, Vujcic, M, Van de Steen, O, Allen, JA. EMPASIPRUBART (ARGX-117) IN MULTIFOCAL MOTOR NEUROPATHY: INITIAL SAFETY AND EFFICACY DATA OF THE PHASE 2 ARDA STUDY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
SERUM PROTEOME IN GUILLAIN-BARRE SYNDROME USING AN APTAMER-BASED PROTEOMICS PLATFORM
Martín-Aguilar, L, Collet, R, Lleixà, C, Caballero-Avila, M, Tejada-Illa, C, Pascual-Goñi, E, Sedano-Tous, MJ, Casasnovas, C, Gutiérrez-Gutiérrez, G, Pardo-Fernández, J, Rojas, R, Turón, J, Gallardo, E, Cortés-Vicente, E, Llansó, L, García, JM, Farrés, J, Querol, L. SERUM PROTEOME IN GUILLAIN-BARRE SYNDROME USING AN APTAMER-BASED PROTEOMICS PLATFORM. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
CLINICAL AND IMMUNOLOGICAL RELAPSES ARE INFREQUENT IN PATIENTS WITH ANTI-CNTN1 AUTOIMMUNE NODOPATHY
Caballero-Avila, M, Martín-Aguilar, L, Pascual-Goñi, E, Tejada-Illa, C, Collet, R, Rojas-García, R, Gallardo, E, Martínez-Martínez, L, Doneddu, P, Nobile-Orazio, E, de Winter, J, Alonso-Jimenez, A, del Real, MA, Armangué, T, Delmont, E, Xuclà-Ferrarons, T, Roche, JC, Jauregui, A, González, A, Ortiz, N, Liong, HF, de Rivera, FJR, Sparasci, D, Ripellino, P, Pérez-Pérez, H, Guerrero-Sola, A, Vegezzi, E, Baars, A, Jacobs, B, Wieske, L, Eftimov, F, Lleixà, C, Querol, L. CLINICAL AND IMMUNOLOGICAL RELAPSES ARE INFREQUENT IN PATIENTS WITH ANTI-CNTN1 AUTOIMMUNE NODOPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
PHASE 3 TRIAL DESIGNS EVALUATING RILIPRUBART, A C1S-COMPLEMENT INHIBITOR, IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Lewis, RA, Allen, J, Merkies, ISJ, van Doorn, PA, Sommer, C, Wallstroem, E, Luo, XD, Alonso-Alonso, M, Atassi, N, Querol, L. PHASE 3 TRIAL DESIGNS EVALUATING RILIPRUBART, A C1S-COMPLEMENT INHIBITOR, IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
PHASE 2 EFFICACY AND SAFETY OF RILIPRUBART, A C1S-COMPLEMENT INHIBITOR, IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Querol, L, Lewis, RA, Hartung, HP, Van Doorn, PA, Wallstroem, E, Auwarter, K, Luo, XD, Alonso-Alonso, M, Atassi, N, Hughes, RAC. PHASE 2 EFFICACY AND SAFETY OF RILIPRUBART, A C1S-COMPLEMENT INHIBITOR, IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
PHASE 2 TRIAL OF RILIPRUBART IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: QUALITY-OF-LIFE AND FATIGUE
Van Doorn, PA, Querol, L, Hartung, HP, Hughes, RAC, Orsini, M, Hakimi-Hawken, N, Minor, C, Msihid, J, Alonso-Alonso, M, Atassi, N, Lewis, R. PHASE 2 TRIAL OF RILIPRUBART IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: QUALITY-OF-LIFE AND FATIGUE. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
PHASE 2 TRIAL OF RILIPRUBART IN CIDP: EFFECT ON COMPLEMENT BIOMARKERS AND NEUROFILAMENT LIGHT CHAIN
Querol, L, Lewis, RA, Van Doorn, PA, Hughes, RAC, Storek, M, Rajagopal, V, Chow, T, Luo, XD, Alonso-Alonso, M, Atassi, N, Hartung, HP. PHASE 2 TRIAL OF RILIPRUBART IN CIDP: EFFECT ON COMPLEMENT BIOMARKERS AND NEUROFILAMENT LIGHT CHAIN. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
CLINICAL AND GENETIC SPECTRUM OF PATIENTS WITH BAG3-RELATED NEUROMUSCULAR DISORDERS IN EUROPE
Fernandez-Eulate, G, Gitiaux, C, Thiele, S, Jungbluth, H, Audic, F, Potulska-Chromik, A, Marini-Bettolo, C, Davion, JB, de la Tassa, GM, Olivé, M, de la Hoz, CPDF, Isapof, A, Töpf, A, Walter, M, Angelini, C, Claeys, K, Kostera-Pruszczyk, A, Attarian, S, Straub, V, Domínguez-González, C, Vissing, J, Metay, C, Khraiche, D, Wahbi, K, Stojkovic, T. CLINICAL AND GENETIC SPECTRUM OF PATIENTS WITH BAG3-RELATED NEUROMUSCULAR DISORDERS IN EUROPE. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
EFFICACY AND SAFETY OF SUBCUTANEOUS (SC) EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: ADHERE/ADHERE plus TRIALS
Allen, J, Van Doorn, PA, Basta, I, Dysgaard, T, Eggers, C, Guptill, J, Gwathmey, K, Hewamadduma, C, Hofman, E, Hussain, Y, Kuwabara, S, Le Masson, G, Leypoldt, F, Lin, J, Lipowska, M, Lowe, M, Pinter, GL, Querol, L, Simu, MA, Chang, T, Tse, A, Ulrichts, P, Van Hoorick, B, Yamasaki, R, Lewis, RA. EFFICACY AND SAFETY OF SUBCUTANEOUS (SC) EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: ADHERE/ADHERE plus TRIALS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2024; 29DOI:. PMID:. IF:3.200(Q2/4D).
01/08/2024
Assessing predictors of adequate individual buprenorphine maintenance dosage for the treatment of opioid use disorder: Listening to the patient
González-Saiz, F, Vergara-Moragues, E, Trujols, J, Alcaraz, S, de los Cobos, JP. Assessing predictors of adequate individual buprenorphine maintenance dosage for the treatment of opioid use disorder: Listening to the patient. INTERNATIONAL JOURNAL OF DRUG POLICY. 2024; 130DOI:10.1016/j.drugpo.2024.104519. PMID:39024687. IF:4.400(Q1/1D).
01/08/2024
Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study
Clougher, D, Forte, MF, Mezquida, G, Sánchez-Torres, AM, Serra-Navarro, M, Penadés, R, Lobo, A, Pinto, AG, Panadero, R, Roldán, A, Vieta, E, de la Serna, E, Trabsa, A, Martínez-Aran, A, Torrent, C, Tortorella, A, Menculini, G, Ramos-Quiroga, JA, Cuesta, MJ, Bernardo, M, Amoretti, S. Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024; 85DOI:10.1016/j.euroneuro.2024.05.006. PMID:39013243. IF:6.700(Q1/1D).
01/08/2024
Functioning in schizophrenia: Recommendations of an expert panel
Corripio, I, Fraguas, D, García-Portilla, MP, Olivares, JM, Sierra, P, Sánchez, P. Functioning in schizophrenia: Recommendations of an expert panel. SCHIZOPHRENIA RESEARCH. 2024; 270DOI:10.1016/j.schres.2024.06.050. PMID:38964076. IF:3.500(Q1/3D).
01/08/2024
Cortical and Subcortical Brain Alterations in Specific Phobia and Its Animal and Blood-Injection-Injury Subtypes: A Mega-Analysis From the ENIGMA Anxiety Working Group
Hilbert, K, Boeken, OJ, Langhammer, T, Groenewold, NA, Bas-Hoogendam, JM, Aghajani, M, Zugman, A, Åhs, F, Arolt, V, Beesdo-Baum, K, Björkstrand, J, Blackford, JU, Blanco-Hinojo, L, Böhnlein, J, Bülow, R, Cano, M, Cardoner, N, Caseras, X, Dannlowski, U, Domschke, K, Fehm, L, Feola, B, Fredrikson, M, Goossens, L, Grabe, HJ, Grotegerd, D, Gur, RE, Hamm, AO, Harrewijn, A, Heinig, I, Herrmann, MJ, Hofmann, D, Jackowski, AP, Jansen, A, Kaczkurkin, AN, Kindt, M, Kingsley, EN, Kircher, T, Klahn, AL, Koelkebeck, K, Krug, A, Kugel, H, Larsen, B, Leehr, EJ, Leonhardt, L, Lotze, M, Margraf, J, Michalowski, J, Muehlhan, M, Nenadic, I, Pan, PM, Pauli, P, Peñate, W, Pittig, A, Plag, J, Pujol, J, Richter, J, Rivero, FL, Salum, GA, Satterthwaite, TD, Schäfer, A, Schäfer, J, Schienle, A, Schneider, S, Schrammen, E, Schruers, K, Schulz, SM, Seidl, E, Stark, RM, Stein, F, Straube, B, Straube, T, Ströhle, A, Suchan, B, Thomopoulos, SI, Ventura-Bort, C, Visser, R, Völzke, H, Wabnegger, A, Wannemüller, A, Wendt, J, Wiemer, J, Wittchen, HU, Wittfeld, K, Wright, B, Yang, Y, Zilverstand, A, Zwanzger, P, Veltman, DJ, Winkler, AM, Pine, DS, Jahanshad, N, Thompson, PM, Stein, DJ, Van der Wee, NJ, Lueken, U. Cortical and Subcortical Brain Alterations in Specific Phobia and Its Animal and Blood-Injection-Injury Subtypes: A Mega-Analysis From the ENIGMA Anxiety Working Group. AMERICAN JOURNAL OF PSYCHIATRY. 2024; 181(8)DOI:10.1176/appi.ajp.20230032. PMID:38859702. IF:14.700(Q1/1D).
01/08/2024
The comparative safety and efficacy of anti-migraine medications and devices in migraine prophylaxis: a network meta-analysis
Nieto, RB, Láinez, MJ, Huth, M, Francis, P, Singh, S, McMaster, A, Hasham, SN, Suthar, B, Srivastava, PK. The comparative safety and efficacy of anti-migraine medications and devices in migraine prophylaxis: a network meta-analysis. JOURNAL OF HEADACHE AND PAIN. 2024; 25DOI:. PMID:. IF:7.900(Q1/1D).
01/08/2024
RE-START STUDY: Multicenter study to assess response after reintroduction of anti-CGRP antibodies in patients with migraine
Martínez, AG, del Rincón, CR, Gutierrez, SQ, Azorín, DG, Lázaro, IF, Peral, ALG, Osorio, YG, Díez, FI, Iñiguez, AE, Luque, SG, Villanueva, MH, Díaz, SC, Vendrell, AM, Juanes, FV, Ros, AL, Soblechero, AS, Sánchez-Mateos, NM, Belvis, R, Zubizarreta, IK, Urabayen, AE, Rodrígue-Vico, JS, Sanchez, AJ, García, AG, Pérez, MPN, Montes, N, Gago-Viega, A. RE-START STUDY: Multicenter study to assess response after reintroduction of anti-CGRP antibodies in patients with migraine. JOURNAL OF HEADACHE AND PAIN. 2024; 25DOI:. PMID:. IF:7.900(Q1/1D).
01/08/2024
Radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal sarcomatosis: Results from a reference center and considerations based on current evidence
Casares, FCM, Ruiz, FJP, de Pedro, CG, Barbadillo, JG, Broto, JM, González, FA, Gómez, DD, Fernández-Hernández, JA, López, JAG, Pascual, JMA. Radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal sarcomatosis: Results from a reference center and considerations based on current evidence. CIRUGIA ESPANOLA. 2024; 102(8)DOI:10.1016/j.ciresp.2024.05.006. PMID:. IF:1.300(Q3/7D).
01/08/2024
Recommendations on self-management interventions for adults living with obesity: COMPAR-EU project
Medina-Aedo, M, Beltran, J, Valli, C, Canelo-Aybar, C, Song, Y, Ballester, M, Bowman-Busato, J, Christogiannis, C, Grammatikopoulou, MG, Groene, O, Heijmans, M, Hoogendorn, M, Killeen, SL, Kontouli, KM, Mavridis, D, Minambres, I, Mueller, BS, de Guzman, EN, Noordman, J, Orrego, C, Perestelo-Perez, L, Saz-Parkinson, Z, Seitidis, G, Sunol, R, Tsokani, S, Alonso-Coello, P. Recommendations on self-management interventions for adults living with obesity: COMPAR-EU project. Clinical Obesity. 2024; 14(4)DOI:10.1111/cob.12667. PMID:38757917. IF:(Q/D).
01/08/2024
Overall prognosis of index lung cancer recurrence or of second primary lung cancer in people with non-small cell lung cancer operated with complete resection.
Laforge, Louis, Eberst, Guillaume, Calais, Francois, Malouf, Reem S, Marchal, Corynne, Westeel, Virginie, Roque-Figuls, Marta. Overall prognosis of index lung cancer recurrence or of second primary lung cancer in people with non-small cell lung cancer operated with complete resection.. COCHRANE DATABASE OF SYSTEMATIC REVIEWS. 2024; 8DOI:10.1002/14651858.CD015319. PMID:. IF:(Q/D).
01/08/2024
Unravelling urban nesting site selection in an opportunistic gull: an integrated analysis of micro-spatial habitat and litter quantification
Martín-Vélez, V, Domingo, J, Cardador, L, Montalvo, T, Navarro, J. Unravelling urban nesting site selection in an opportunistic gull: an integrated analysis of micro-spatial habitat and litter quantification. EUROPEAN JOURNAL OF WILDLIFE RESEARCH. 2024; 70(4)DOI:10.1007/s10344-024-01822-2. PMID:. IF:2.000(Q1/2D).
01/08/2024
Dexketoprofen Trometamol and Tramadol Hydrochloride Fixed-Dose Combination in Moderate to Severe Acute Low Back Pain: A Phase IV, Randomized, Parallel Group, Placebo, Active-Controlled Study (DANTE)
Varrassi, G, Hanna, M, Coaccioli, S, Fabrizzi, P, Baldini, S, Kruljac, I, Brotons, C, Perrot, S. Dexketoprofen Trometamol and Tramadol Hydrochloride Fixed-Dose Combination in Moderate to Severe Acute Low Back Pain: A Phase IV, Randomized, Parallel Group, Placebo, Active-Controlled Study (DANTE). Pain and Therapy. 2024; 13(4)DOI:10.1007/s40122-024-00623-4. PMID:38922520. IF:3.300(Q2/4D).
01/08/2024
Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn's disease patients
Salazar, J, Riera, P, Gordillo, J, Altès, A, Martínez, M, Serès, M, Llaó, J, Giordano, A, Garcia-Planella, E. Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn's disease patients. PHARMACOGENOMICS JOURNAL. 2024; 24(4)DOI:10.1038/s41397-024-00341-2. PMID:38906864. IF:2.900(Q2/4D).
01/08/2024
Long-term effect of obstructive sleep apnoea management on blood pressure in patients with resistant hypertension: the SARAH study
Torres, G, Sánchez-de-la-Torre, M, Gracia-Lavedan, E, Benitez, ID, Martinez, D, Dalmases, M, Pinilla, L, Minguez, O, Vaca, R, Pascual, L, Aguilá, M, Cortijo, A, Gort, C, Martinez-Garcia, MA, Mediano, O, Peralta, SR, Fortuna-Gutierrez, AM, Marquez, PP, Drager, LF, Cabrini, M, de Barros, S, Masa, JF, Peñafiel, JC, Felez, M, Vázquez, S, Abad, J, García-Rio, F, Casitas, R, Lee, CH, Barbé, F. Long-term effect of obstructive sleep apnoea management on blood pressure in patients with resistant hypertension: the SARAH study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64(2)DOI:10.1183/13993003.00269-2024. PMID:39060017. IF:21.000(Q1/1D).
01/08/2024
The ESTRO-EFOMP core curriculum: a joint effort from European medical physics experts in Radiation oncology
Jornet, N. The ESTRO-EFOMP core curriculum: a joint effort from European medical physics experts in Radiation oncology. RADIOTHERAPY AND ONCOLOGY. 2024; 197DOI:. PMID:. IF:5.300(Q1/2D).
01/08/2024
Transit dosimetry with EPID
Jornet, N. Transit dosimetry with EPID. RADIOTHERAPY AND ONCOLOGY. 2024; 197DOI:. PMID:. IF:5.300(Q1/2D).
01/08/2024
Hospital pharmacy towards 2030
de Gamarra-Martínez, EF, Tortajada-Goitia, B, Corte-García, JJ, Martín-Herranz, I, García-Gil, M, de la Fuente, JS, Nicolás-Picó, J. Hospital pharmacy towards 2030. Farmacia Hospitalaria. 2024; 48DOI:10.1016/j.farma.2024.05.004. PMID:39097369. IF:(Q/D).
01/08/2024
Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search
Puig, L, Fujita, H, Thaçi, D, Zheng, M, Daly, ACH, Leonardi, C, Lebwohl, MG, Barker, J. Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search. Dermatology and Therapy. 2024; 14(9)DOI:10.1007/s13555-024-01230-z. PMID:39088126. IF:4.200(Q1/1D).
01/08/2024
Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice
Butrón-Bris, B, Llamas-Velasco, M, Ovejero-Benito, MC, Santos-Juanes, J, Martínez-López, A, Ruiz-Villaverde, R, Roustan, G, Baniandrés, O, Izu-Belloso, R, de la Cueva, P, Sahuquillo-Torralba, A, Gónzalez-Quesada, A, Vilarrasa-Rull, E, Pujol-Montcusi, J, García-Martínez, J, Navares, M, Palomar-Moreno, I, Novalbos, J, Abad-Santos, F, Daudén, E, de la Fuente, H. Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice. EXPERIMENTAL DERMATOLOGY. 2024; 33(8)DOI:10.1111/exd.15152. PMID:39081053. IF:3.100(Q2/3D).
01/08/2024
A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets
Rusinol, L, Puig, L. A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(15)DOI:10.3390/ijms25158437. PMID:39126010. IF:4.900(Q1/3D).
01/08/2024
Lentigo maligna: a comprehensive review on diagnosis and treatment
Carmona-Rocha, E, Rusiñol, L, Garcia-Melendo, C, Iznardo, H, Mozos, A, López-Sánchez, C, Yélamos, O. Lentigo maligna: a comprehensive review on diagnosis and treatment. Italian Journal of Dermatology and Venereology. 2024; 159(4)DOI:10.23736/S2784-8671.24.07837-X. PMID:39069838. IF:2.600(Q2/4D).
01/08/2024
Cardiac index-guided therapy to maintain optimised postinduction cardiac index in high-risk patients having major open abdominal surgery: the multicentre randomised iPEGASUS trial
Funcke, S, Schmidt, G, Bergholz, A, Navarro, PA, Cabezón, GA, Barbero-Espinosa, S, Diaz-Cambronero, O, Edinger, F, García-Gregorio, N, Habicher, M, Klinkmann, G, Koch, C, Kröker, A, Mencke, T, García, VM, Zitzmann, A, Lezius, S, Pepic, A, Sessler, DI, Sander, M, Haas, SA, Reuter, DA, Saugel, B. Cardiac index-guided therapy to maintain optimised postinduction cardiac index in high-risk patients having major open abdominal surgery: the multicentre randomised iPEGASUS trial. BRITISH JOURNAL OF ANAESTHESIA. 2024; 133(2)DOI:10.1016/j.bja.2024.03.040. PMID:38797635. IF:9.200(Q1/1D).
01/08/2024
Current Standards for Training in Robot-assisted Surgery and Endourology: A Systematic Review
Basile, G, Gallioli, A, Diana, P, Gallagher, A, Larcher, A, Graefen, M, Harke, N, Traxer, O, Tilki, D, Van Der Poel, H, Emiliani, E, Angerri, O, Wagner, C, Montorsi, F, Wiklund, P, Somani, B, Buffi, N, Mottrie, A, Liatsikos, E, Breda, A. Current Standards for Training in Robot-assisted Surgery and Endourology: A Systematic Review. EUROPEAN UROLOGY. 2024; 86(2)DOI:10.1016/j.eururo.2024.04.008. PMID:38644144. IF:25.200(Q1/1D).
01/08/2024
Clavipectoral Fascia and Clavipectoral Fascia Plane Block: To Be or Not to Be
Heredia-Carqués, C, Labandeyra, H, Castellanos, M, Váldes-Vilches, LF, Tomás, X, Sala-Blanch, X. Clavipectoral Fascia and Clavipectoral Fascia Plane Block: To Be or Not to Be. ANESTHESIA AND ANALGESIA. 2024; 139(2)DOI:10.1213/ANE.0000000000006837. PMID:38470823. IF:3.800(Q1/1D).
01/08/2024
Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports.
Larrosa MN, Canut-Blasco A, Benito N, Cantón R, Cercenado E, Docobo-Pérez F, Fernández-Cuenca F, Fernández-Domínguez J, Guinea J, López-Navas A, Moreno MÁ, Morosini MI, Navarro F, Martínez-Martínez L, Oliver A. Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports.. Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2024; 41(7)DOI:10.1016/j.eimce.2022.09.002. PMID:36175285. IF:(Q/D).
01/08/2024
A Comprehensive Review of the Pleiotropic Effects of Ticagrelor
Triska, J, Maitra, N, Deshotels, MR, Haddadin, F, Angiolillo, DJ, Vilahur, G, Jneid, H, Atar, D, Birnbaum, Y. A Comprehensive Review of the Pleiotropic Effects of Ticagrelor. CARDIOVASCULAR DRUGS AND THERAPY. 2024; 38(4)DOI:10.1007/s10557-022-07373-5. PMID:36001200. IF:3.100(Q2/4D).